David Rhinesmith

Orrick, Herrington & Sutcliffe LLP

+ Follow Contact

Latest Posts › Whistleblowers

Share:

DEI Executive Order Implies Threat of FCA Litigation

On January 21, 2025, the Trump Administration issued Executive Order 14173 focused on diversity, equity and inclusion (“DEI”) programs and their use in the public and private sectors. This Executive Order links compliance...more

2/14/2025 / Anti-Discrimination Policies , Diversity and Inclusion Standards (D&I) , Employment Discrimination , Executive Orders , False Claims Act (FCA) , Federal Contractors , OFCCP , Retaliation , Whistleblowers

The False Claims Act: How a Recent Decision Rejecting Qui Tam Lawsuits May Affect Enforcement

For over 160 years, the False Claims Act has let people bring claims on behalf of the U.S. government alleging fraud. In exchange, those individuals receive a portion of any recovery. In September, a federal district judge...more

12/13/2024 / Appointments Clause , Article II , Constitutional Challenges , Department of Justice (DOJ) , Dismissals , False Claims Act (FCA) , Qui Tam , Relators , Whistleblowers

The DOJ’s Focus on Clinical Trial Enforcement: An Ounce of Prevention Is Better Than an Enforcement Action Cure

In early April, the U.S. Department of Justice (DOJ) Civil Division’s Consumer Protection Branch (CPB) published its first-ever “Recent Highlights” report. The report provides background on the CPB, highlights from its recent...more

4/27/2022 / Clinical Trials , Cybersecurity , Data Privacy , Deferred Prosecution Agreements , Department of Justice (DOJ) , Enforcement Priorities , False Claims Act (FCA) , Food and Drug Administration (FDA) , Popular , Whistleblowers

3 Results

View per page

Page: of 1